BW
ABBV icon

Basepoint Wealth’s AbbVie ABBV Stock Holding History

Basepoint Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Sell
7,030
-223
-3% -$49.5K 0.87% 16
2025
Q4 		$1.66M Sell
7,253
-159
-2% -$36.2K 1.01% 13
2025
Q3 		$1.72M Buy
7,412
+24
+0.3% +$4.89K 1.22% 12
2025
Q2 		$1.37M Sell
7,388
-19
-0.3% -$3.53K 1.06% 16
2025
Q1 		$1.55M Buy
7,407
+108
+1% +$21K 1.21% 14
2024
Q4 		$1.3M Buy
7,299
+1
+0% +$184 1.03% 18
2024
Q3 		$1.44M Buy
7,298
+404
+6% +$75.4K 1.06% 17
2024
Q2 		$1.18M Sell
6,894
-170
-2% -$28.2K 0.93% 21
2024
Q1 		$1.29M Buy
7,064
+51
+0.7% +$8.79K 0.97% 20
2023
Q4 		$1.09M Buy
7,013
+61
+0.9% +$8.89K 0.87% 23
2023
Q3 		$1.04M Sell
6,952
-11
-0.2% -$1.61K 0.85% 29
2023
Q2 		$938K Sell
6,963
-326
-4% -$47.8K 0.78% 32
2023
Q1 		$1.16M Sell
7,289
-171
-2% -$26.1K 0.97% 21
2022
Q4 		$1.21M Sell
7,460
-137
-2% -$21K 1.07% 17
2022
Q3 		$1.02M Buy
7,597
+477
+7% +$68.4K 1.09% 17
2022
Q2 		$1.09M Buy
7,120
+174
+3% +$26.6K 1.14% 16
2022
Q1 		$1.13M Sell
6,946
-1,275
-16% -$185K 1.04% 19
2021
Q4 		$1.11M Buy
+8,221
New +$971K 1.09% 19

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Basepoint Wealth's ABBV Position: Q1 2026 in Review

Basepoint Wealth reduced its AbbVie (ABBV) stake by 3.1% in Q1 2026, selling an estimated $49.5K and leaving 7,030 shares worth $1.53M. The position accounts for 0.87% of the portfolio, ranked #16.

Basepoint Wealth first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.72M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Basepoint Wealth held 7,030 shares of AbbVie worth $1.53M as of Q1 2026.
  • Basepoint Wealth sold 223 AbbVie shares in Q1 2026, an estimated $49.5K.
  • AbbVie made up 0.87% of Basepoint Wealth's portfolio in Q1 2026, its #16 holding.
  • Basepoint Wealth first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Basepoint Wealth's AbbVie position peaked at $1.72M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.